NASDAQ:ANIP
ANI Pharmaceuticals Stock News
$69.13
-0.560 (-0.80%)
At Close: Mar 28, 2024
ANI Pharmaceuticals (ANIP) Rises Yet Lags Behind Market: Some Facts Worth Knowing
07:01pm, Monday, 29'th Jan 2024
ANI Pharmaceuticals (ANIP) reachead $55.02 at the closing of the latest trading day, reflecting a +0.7% change compared to its last close.
ANI Pharmaceuticals (ANIP) Beats Stock Market Upswing: What Investors Need to Know
07:06pm, Monday, 22'nd Jan 2024
In the most recent trading session, ANI Pharmaceuticals (ANIP) closed at $56.17, indicating a +1.37% shift from the previous trading day.
ANI Pharmaceuticals (ANIP) Stock Drops Despite Market Gains: Important Facts to Note
07:21pm, Friday, 19'th Jan 2024
ANI Pharmaceuticals (ANIP) closed at $55.41 in the latest trading session, marking a -0.32% move from the prior day.
ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
09:26am, Wednesday, 22'nd Nov 2023
BAUDETTE, Minn., Nov. 22, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President & CEO, will participate at the Piper San
ANI Pharmaceuticals, Inc. (ANIP) Q3 2023 Earnings Call Transcript
11:59am, Wednesday, 08'th Nov 2023
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET Company Participants Judy DiClemente - Insight Communications IR Nikhil Lalwani - President and CE
ANI Pharmaceuticals (ANIP) Stock Drops Despite Market Gains: Important Facts to Note
07:32pm, Wednesday, 01'st Nov 2023
ANI Pharmaceuticals (ANIP) closed at $61.66 in the latest trading session, marking a -0.13% move from the prior day.
ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET
06:50am, Wednesday, 25'th Oct 2023
BAUDETTE, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2023 financ
ANI Pharmaceuticals (ANIP) Increases Despite Market Slip: Here's What You Need to Know
07:33pm, Friday, 20'th Oct 2023
ANI Pharmaceuticals (ANIP) closed at $57.44 in the latest trading session, marking a +0.23% move from the prior day.
ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: Here's Why
07:32pm, Friday, 06'th Oct 2023
The latest trading day saw ANI Pharmaceuticals (ANIP) settling at $58.39, representing a -0.41% change from its previous close.
ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
04:05pm, Monday, 18'th Sep 2023
BAUDETTE, Minn., Sept. 18, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief
Here's Why You Should Add ANI Pharmaceuticals (ANIP) to Your Portfolio
03:47pm, Monday, 11'th Sep 2023
ANI Pharmaceuticals (ANIP), a top-ranked stock, has a diverse portfolio of rare disease and generic medicines. Its Purified Cortrophin Gel is witnessing incremental sales in recent quarters.
ANI (ANIP) Is a Great Choice for 'Trend' Investors, Here's Why
10:32am, Friday, 08'th Sep 2023
If you are looking for stocks that are well positioned to maintain their recent uptrend, ANI (ANIP) could be a great choice. It is one of the several stocks that passed through our "Recent Price Stren
What Makes ANI (ANIP) a New Strong Buy Stock
01:32pm, Friday, 25'th Aug 2023
ANI (ANIP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for August 25th
08:16am, Friday, 25'th Aug 2023
ANIP, NVMI, AZPN, GRNT and CVLG have been added to the Zacks Rank #1 (Strong Buy) List on August 25, 2023.
ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
06:50am, Thursday, 24'th Aug 2023
BAUDETTE, Minn., Aug. 24, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief